Does Fludrocortisone Acetate Interact with Methandrostenolone?
CDI records a moderate classification for Fludrocortisone Acetate and Methandrostenolone. The stored summary is: Enhanced tendency toward edema. Use caution, especially in patients with hepatic or cardiac disease. The mechanism involves enhanced edema tendency. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Enhanced edema tendency
What To Tell Your Doctor or Pharmacist
If you are taking Fludrocortisone Acetate and your doctor is considering prescribing Methandrostenolone (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider